Johnson & Johnson announced Monday it could have a coronavirus vaccine ready for human testing by September. The company said it has selected a lead vaccine candidate from constructs it's been working ...
WASHINGTON - On Tuesday, U.S. officials recommended a "pause" on the use of the Johnson & Johnson COVID-19 vaccine in order to investigate U.S. reports of a rare type of blood clot following ...
Results from early stage trials of Johnson & Johnson’s COVID-19 vaccine are promising, showing the one-dose vaccine generates an immune response in nearly all volunteers, with minimal side effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results